Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 1Dermatologic 1CNS 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Medullary 1Adenocarcinoma, Follicular 1

Interventions

Paclitaxel 4fosbretabulin 3Radiotherapy 3selpercatinib 2Filgrastim 2Everolimus 2Doxorubicin 2Cisplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1sargramostim 1repotrectinib 1pralsetinib 1pentetreotide 1pegfilgrastim 1mercaptoundecahydrododecaborate 1gallium Ga 68 dotatate 1fostamatinib 1entrectinib 1combretastatin 1alectinib 1aldesleukin 1Triiodothyronine 1Thyrotropin Alfa 1Thyrotropin 1Thalidomide 1Tamoxifen 1Semaxinib 1Rosiglitazone 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Semaxinib × Endocrine × Clear all
NCT00005647 2010-06-10

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡